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INTRODUCTION
Segregation of the germline from the soma is a central feature
of animal development. In Drosophila, the germline is
determined through the activities of maternally expressed
RNAs and proteins which colocalize in the pole plasm at the
posterior pole of the egg (reviewed by Rongo and Lehmann,
1996). Pole cells, the progenitors of the germline, form very
early in embryogenesis, then, beginning at gastrulation, they
migrate into the interior of the embryo and ultimately associate
with the gonadal mesoderm to form the embryonic gonads
(reviewed by Williamson and Lehmann, 1996). Beginning in
larval development, germ cells proliferate and differentiate in
order to carry out spermatogenesis and oogenesis; among the
structures assembled during oogenesis is new pole plasm,
which specifies the germline for the subsequent generation of
individuals. 
Genetic and molecular studies have identified numerous
genes which are required for pole plasm assembly and
subsequent posterior segment specification and germ cell
formation; many of these genes are expressed during oogenesis
and produce mRNAs and/or proteins which localize in pole
plasm or in polar granules, specialized organelles contained
within the pole plasm (reviewed by Rongo and Lehmann,
1996). Analysis of the expression of these genes supports an
early hypothesis (Mahowald, 1968) that translational control is
a major mechanism regulating Drosophila germline
development. The product of the vasa (vas) gene, a DEAD-
box-family protein which is localized in polar granules and
which shares the enzymatic functions of the translation
initiation factor eIF4A (Hay et al., 1988; Lasko and Ashburner,
1988; Liang et al., 1994), is a candidate germline-specific
translational regulator. For instance, levels of the short isoform
of OSKAR protein (OSK), a molecule central to pole plasm
assembly (Ephrussi et al., 1991; Kim-Ha et al., 1991; Ephrussi
and Lehmann, 1992), are greatly reduced in vas mutant ovaries
(Markussen et al., 1995; Rongo et al., 1995). Another pole
plasm mRNA whose translation may be activated by VAS is
nanos (nos), as nos RNA carrying an intact translational
regulation element in its 3¢ UTR is completely inactive in
embryos derived from vas mutant ovaries (Gavis et al., 1996;
Dahanukar and Wharton, 1996).
While the activities of pole plasm components such as VAS
have been most thoroughly studied with respect to their
function in pole cell formation and specification of the
posterior soma, clearly some genes involved in pole plasm
assembly also function in other stages of germline
development. For instance, females homozygous for either of
two strong nos alleles exhibit defects in germ cell proliferation
(Lehmann and Nüsslein-Volhard, 1991; Wang et al., 1994).
Furthermore, pole cells lacking maternal nos function fail to
complete migration and do not associate with the embryonic
gonadal mesoderm (Kobayashi et al., 1996), indicating a role
for nos in the transition from pole cell to functional germ cell.
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The Drosophila gene vasa is required for pole plasm
assembly and function, and also for completion of
oogenesis. To investigate the role of vasa in oocyte
development, we generated a new null mutation of vasa,
which deletes the entire coding region. Analysis of vasa-null
ovaries revealed that the gene is involved in the growth of
germline cysts. In vasa-null ovaries, germaria are
atrophied, and contain far fewer developing cysts than do
wild-type germaria; a phenotype similar to, but less severe
than, that of a null nanos allele. The null mutant also
revealed roles for vasa in oocyte differentiation, anterior-
posterior egg chamber patterning, and dorsal-ventral
follicle patterning, in addition to its better-characterized
functions in posterior embryonic patterning and pole cell
specification. The anterior-posterior and dorsal-ventral
patterning phenotypes resemble those observed in gurken
mutants. vasa-null oocytes fail to efficiently accumulate
many localized RNAs, such as Bicaudal-D, orb, oskar, and
nanos, but still accumulate gurken RNA. However, GRK
accumulation in the oocyte is severely reduced in the
absence of vasa function, suggesting a function for VASA
in activating gurken translation in wild-type ovaries.
Key words: Drosophila, RNA localization, axis patterning, vasa
(vas), oogenesis
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Similarly, various vas alleles have defects in oogenesis and lay
few or no eggs (Lasko and Ashburner, 1988, 1990; Lehmann
and Nüsslein-Volhard, 1991; Schüpbach and Wieschaus,
1991). Females trans-heterozygous for Df(2L)A267 and
Df(2L)TE116-GW18, two large deletion mutations which both
include vas, were reported to be blocked in early vitellogenic
stages of oogenesis (Lasko and Ashburner, 1988). Analysis of
whether this phenotype was caused solely by loss of vas
function has been confounded by the fact that these trans-
heterozygous deficiency lines are haploid for a large number
of genes, but that, aside from large deficiencies, a clearly null
allele of vas did not exist. Four EMS-induced alleles of vas,
vasD1, vasQ6, vasQ7 and vasD5, also lead to greatly reduced
fertility, with many egg chambers blocked as for the trans-
heterozygous deficiency females (Lehmann and Nüsslein-
Volhard, 1991). The few eggs produced by females
homozygous for these alleles often lack dorsal appendages and
have the micropyle, a specialized vitelline membrane structure
normally found only at the anterior of the egg, duplicated at
the posterior (Lehmann and Nüsslein-Volhard, 1991). Again,
whether these phenotypes represent the results of a complete
loss of vas function is unknown. vasQ6 and vasD5 are missense
mutations which alter single amino acids of VAS and both
alleles produce substantial amounts of mutant protein (Liang
et al., 1994), so neither of these mutations is likely to be null.
For vasD1 and vasQ7 the molecular nature of the mutation is
unknown, but the vas coding region is unaffected in these
mutant alleles.
In this paper, we have used a new vas null allele, vasPH165,
a small deletion which we generated by imprecise P-element
excision, to investigate in detail the role of vas in events of
oogenesis prior to pole plasm assembly. We found that
abrogation of vas function results in defects in many aspects
of oogenesis including control of cystocyte divisions, oocyte
differentiation, and specification of posterior and dorsal follicle
cell-derived structures. Furthermore, vasPH165 oocytes only
weakly concentrate many oocyte-localized RNAs, although
some oocyte-specific molecules, including gurken (grk;
Schüpbach, 1987; Neuman-Silberberg and Schüpbach, 1993)
RNA, remain concentrated in the oocyte in vas mutant ovaries.
However, in the case of grk, translation is severely reduced in
the absence of vas function. This provides evidence that VAS
is involved in translational control mechanisms operating in
early stages of oogenesis.
MATERIALS AND METHODS
Fly stocks
To create a null allele of vas, excision lines were generated through
the introduction of the D 2-3 transposase source into vasP(ry[+])LYG2
(Rittenhouse and Berg, 1995). To do this, +/Y; vasP(ry[+])LYG2 cn; ry506
males were crossed to w; Bic-DPA66 Su(Bic-DPA66) cn/CyO; D 2-
3Sb/TM3 Ser virgin females. w/Y; vasP(ry[+])LYG2 cn/CyO; D 2-3Sb/
ry506 males were then crossed to +/+; l(2)05084P(ry[+]l(2)05084/CyO;
ry506 virgin females. Individual ry F1 males representing excisions of
vasP(ry[+])LYG2 were then individually crossed to
l(2)05084P(ry[+]l(2)05084/CyO; ry506 virgin females. Balanced ry stocks
were generated and females homozygous for an excision chromosome
were crossed to Oregon R males to test for fertility. Excision lines
were screened for deletions through Southern analysis using a 1.9-kb
EcoRI genomic fragment from the vas first intron, and which includes
the vasP(ry[+])LYG2 insertion site, as a probe. VAS protein levels from
excision lines were determined by western analysis. 
vasP(ry[+])LYG2 was provided by Celeste Berg (University of
Washington, Seattle); l(2)05084P(ry[+]l(2)05084/CyO was provided by
the Berkeley Drosophila Genome Project; nosRC, which disrupts a
splice donor site and is null for RNA and protein expression (Wang
et al., 1994; Curtis et al., 1997) was received from Takahiro Akiyama
(Azabu University, Kanagawa, Japan); and grkHK36, a strong grk allele
(Schüpbach, 1987) was obtained from Trudi Schüpbach (Princeton
University). The wild-type strain employed was Oregon R.
In situ hybridization and antibody staining
In situ hybridizations with DIG-labeled RNA probes and antibody
stainings were carried out on ovaries and embryos as described by
Kobayashi et al. (1998), except that DMSO was omitted from the
fixation solution used for ovaries. Primary antibodies were used at the
following dilutions: a -ORB, 1:20; a -BIC-D, 1:10; a -NOS, 1:150; a -
GRK, 1:3000; a -ADD-87, 1:20. a -NOS was pre-adsorbed with
embryos from nosBN females, and a -GRK was preadsorbed with
grkHK36 ovaries. For bright-field microscopy, antibody stainings were
detected with DAB, enhanced using the Vectastain ABC or ABC Elite
kits (Vector Laboratories) and biotinylated secondary antibodies. For
confocal microscopy, antibody stainings were detected using Texas
Red-conjugated secondary antibodies (Molecular Probes). b -gal
staining of khc:lacZ ovaries was carried out as described by Clark et
al. (1994).
OliGreen/Texas Red-phalloidin staining
Ovaries were dissected in PBS and fixed for 20 minutes in a mixture
of 600 m l heptane, 200 m l 4% paraformaldehyde in PBS + 0.2%
Tween-20, and 20 m l DMSO. Following fixation, samples were rinsed
3 times with PBT (PBS + 0.1% Tween-20), incubated for 1 hour in
RNase A (100 mg/ml), and rinsed again 3 times with PBT. Ovaries
were incubated for 1 hour in OliGreen (Molecular Probes, 1:1000
dilution) and Texas Red-phalloidin (Molecular Probes), washed with
PBT, and mounted in 70% glycerol in PBS.
RESULTS
vasPH165 is a vas null allele
Identification of additional vas cDNA clones has indicated the
presence of a 127-bp exon upstream of the previously reported
5¢ end of vas, which extends the 5 ¢ UTR of the gene. This exon
is separated by a large intron of 6603 bp from the remainder
of the gene (Fig. 1A,B; Berkeley Drosophila Genome Project,
unpublished results, submitted to GenBank under accession
numbers L81347, L81348, L81449, AC000466, and
AC000469). vasLYG2 is a P-element-induced vas allele
(Rittenhouse and Berg, 1995), which we mapped to the large
first intron of vas (Fig. 1A), and which produces about 2% of
the wild-type level of VAS (Fig. 1C), a level essentially
undetectable in tissue staining experiments. Despite the very
low level of VAS in vasLYG2 ovaries its phenotype is
hypomorphic; oogenesis in vasLYG2 females is less severely
compromised than in Df(2L)A267/Df(2L)TE116-GW18 flies,
and vasLYG2 females lay numerous eggs. This suggested to us
either that trace amounts of VAS are sufficient for oogenesis
to often proceed to completion, or that the more severe
phenotype observed in the double-deficiency lines results from
the effects of a reduction in dosage of a second gene which
enhances the vas phenotype. 
To distinguish between these possibilities, it was necessary to
obtain a molecularly characterizable null vas allele. For this
S. Styhler and others
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purpose, we generated a series of derivative lines by mobilizing
the P element in vasLYG2. Out of 201 excision events, stable lines
were generated from 129. Of these, 119 caused reversion to a
wild-type phenotype, indicating that the vasLYG2 phenotype
results solely from the P-element insertion, and that the vasLYG2
chromosome is free of other female-sterile mutations. Three
other derivatives were recessive lethal, and seven, although
having excised the ry+ marker on the P element of vasLYG2,
remained defective in oogenesis. These were checked by PCR
and Southern blots to determine whether they carried a deletion
confined to the vas gene, and by western blots using anti-VAS
antiserum to determine whether they expressed VAS. From these
analyses, one line, vasPH165, was identified, which produced no
detectable VAS protein and carried a 7343-bp deletion which
removes the entire coding region of vas (Fig. 1A,C). We
confirmed the breakpoints of vasPH165 by nucleotide sequencing,
comparing the mutant sequence to wild-type sequence provided
by the Berkeley Drosophila Genome Project. From the nature of
the vasPH165 mutation and the fact that no VAS protein is
detectable on western blots even on long overexposures (Fig.
1C), we conclude that vasPH165 is null for VAS. The vasPH165
deletion is mostly limited to vas, as one of its breakpoints lies
within vas and the other is 1270 bp downstream of its 3¢ end. A
nested gene may be located within the 3.5-kb third intron of vas,
which is deleted in vasPH165, as a 3-kb transcript present
throughout all developmental stages is detected on northern blots
using genomic probes including this intron but not with vas
cDNA probes (Lasko and Ashburner, 1988). However, any gene
other than vas which may be disrupted in vasPH165 is almost
certainly irrelevant to the discussion below, as a vas-GFP
transgene, constructed from a vas cDNA fused to the vas
promoter, and therefore lacking any nested or 3¢ -flanking genes,
rescues vasPH165 homozygotes, and Df(2L)A267/ Df(2L)TE116-
GW18 flies to fertility. The phenotypes of vasPH165/vasPH165,
vasPH165/ Df(2L)A267, and Df(2L)A267/ Df(2L)TE116-GW18
ovaries are essentially identical.
VAS is involved in the maintenance of germline
cysts
Upon cursory examination of vasPH165 ovaries under the light
microscope, we noticed an obvious atrophy of the germaria as
compared with the wild-type, suggesting that fewer germ cells
were present. To investigate this more closely, we used an
antibody recognizing ADD-87 protein (Lin et al., 1994; Zaccai
and Lipshitz, 1996) which stains spectrosomes and fusomes,
specific structures present in stem cells, cystoblasts and
dividing cystocyte clusters. In vasPH165 ovaries, a reduction in
the number of ADD-87-staining structures, and therefore a
reduction in the number of developing cysts, is readily apparent
as compared with wild-type (Fig. 2A-D). This phenotype has
high expressivity, and increases in severity with the age of the
female (Fig. 2C-D). In germaria from 7-day-old vasPH165
females, region 1 frequently consists of only a few stem cells
and developing cysts. Posterior to these there is often what
appears to be an extended interfollicular stalk (compare Fig.
2D with Fig. 2C), likely formed by follicle cells in the absence
of cystocyte clusters. This suggests that the cystocyte clusters
remaining in the germarium have ceased to develop further and
have degenerated, while the follicle cells continue to divide.
Two other genes that function in the same pathway as vas in
posterior patterning, nos and pum, have also been implicated
in germ cell proliferation (Lehmann and Nüsslein-Volhard,
1991; Wang et al., 1994; Lin and Spradling, 1997), raising the
possibility that they also may be interacting with vas in the
Fig. 1. (A) Organization of the
vas gene. Exons (boxes) are
numbered with Roman
numerals (I-VIII), the
translational start codon is in
exon II; E, EcoRI site. The site
of the P{ry+, vasLYG2} insertion
is indicated, and the insertion
site is immediately after
position 75581 in the BDGP P1
clone DS00929 (GenBank
accession number AC002502).
vasPH165 results from an
imprecise excision of P{ry+,
vasLYG2}, in which 7343 bp of
genomic DNA, including the
entire vas coding region, are
deleted, and replaced with 16
bp from the P element
(sequence highlighted). (B) The
5¢ UTR of vas. The first 127
nucleotides make up exon I, the
6603-bp first intron follows
after nucleotide 127 (solid
triangle) and nucleotide 128
corresponds to nucleotide 76 as
reported in Lasko and
Ashburner (1988). Nucleotides 151-153 are the initiator ATG (underlined). (C; top panel) Western blot probed with a -VAS antiserum to
compare the levels of VAS in Oregon R, vasLYG2 and vasPH165 ovarian extracts. Extracts were loaded in various amounts as indicated at the top
of the figure. (Bottom panel) The same blot probed with a -eIF4A antiserum (Lavoie, 1995) as a loading control.
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germarium. pum mutants produce ovarioles which contain only
two or three clusters of undifferentiated germ cells which lack
spectrosome/fusome structures or ring canals (Lin and
Spradling, 1997), a phenotype we never observed in vas
mutants. Upon examination of nosRC mutant ovaries with the
a -ADD-87 antibody, we observed a phenotype which appears
similar, but somewhat more severe, than that of vasPH165. Many
nosRC ovarioles consist of a germarium with one to three cysts
(Fig. 2E), followed by an extended stalk and one to three
normal-looking egg chambers. In more extreme cases, only
remnants of spectrosome/fusome material can be detected in
the anterior of the germarium (Fig. 2F), consistent with the
conclusion that these germline cells have arrested
development.
VAS is involved in oocyte differentiation
At a low frequency (aprox. 1% for each), we observed defects
in germline differentiation and oocyte determination in
vasPH165 ovaries, including tumorous egg chambers (Fig. 3A),
egg chambers with 16 nurse cells and no oocyte, others with
two oocytes, and again others with a mislocalized oocyte (Fig.
3B-D). Far more frequently the normal 15 nurse cells and one
oocyte are present; however, by at least two criteria the oocytes
produced in vasPH165 egg chambers are not fully differentiated.
In wild-type development, the nurse cell nuclei endoreplicate
during pre-vitellogenic oogenesis and become highly
polyploid, whereas the oocyte nucleus remains diploid and
condenses into a tight karyosome (Mahowald and Kambysellis,
1980). However, in vasPH165 the oocyte nucleus appears more
diffuse than does the wild-type oocyte nucleus (Fig. 3E,F).
This would be consistent either with a failure to form the
karyosome structure, perhaps involving a premature meiotic
arrest in diplotene rather than in metaphase, or an increase in
ploidy in vasPH165 oocytes. A very similar nuclear morphology
has been observed in spindle (spn) mutant oocytes, which has
been interpreted as resulting from a delay in oocyte
determination (González-Reyes et al., 1997).
Secondly, vasPH165 oocytes do not efficiently accumulate at
least four oocyte-localized RNAs. In wild-type ovaries, the
Bicaudal-D, orb, osk and nos RNAs all accumulate efficiently
in the oocyte within the germarium and remain concentrated
S. Styhler and others
Fig. 2. Confocal micrographs of germaria from (A) wild-type,
(B) grkHK36/grkHK36, (C) 4-day-old vasPH165/vasPH165, (D) 7-day-old
vasPH165/vasPH165, and (E,F) 1- to 2-day old nosRC/nosRC ovaries
stained for the ADD-87 protein, which marks spectrosome and
fusome structures and which is diagnostic for stem cells and
developing germline cysts. Substantially fewer foci of ADD-87 are
observed in all vasPH165 or nosRC germaria as compared with the
wild-type or with grkHK36. Similar phenotypes were observed in
vasPH165/Df(2L)A267 ovaries.
Fig. 3. Phenotypes of vas-null egg chambers affecting oocyte
determination. Confocal micrographs of (A-B) vasPH165/vasPH165
ovaries stained with the nuclear dye Oli-Green (Molecular Probes),
illustrating the following phenotypes: (A) tumorous germline cyst,
(B) 16 nurse cells and no oocyte. The 16 polyploid nuclei are
numbered in this panel. (C) vasPH165/ vasPH165 egg chamber with two
oocytes, stained for F-actin with Texas Red-phalloidin (Molecular
Probes). (D) vasPH165/Df(2L)A267 egg chamber doubly stained with
Oli-Green and with Texas Red-phalloidin, illustrating a bipolar egg
chamber with its oocyte in the center. We also observed bipolar egg
chambers in vasPH165/vasPH165 ovaries. (E,F) Higher-magnification
view of oocyte nuclei stained with Oli-Green; (E) wild-type,
(F) vasPH165/vasPH165. In each of these panels, an arrowhead points
to the oocyte nucleus; note the more diffuse staining in F as
compared with E, apparent in almost all vasPH165 egg chambers.
Similar phenotypes were observed in vasPH165/Df(2L)A267 ovaries.
Scale bars 20 m m (A-C), 100 m m (D), 10 m m (E,F).
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therein throughout the early stages of oogenesis (Ephrussi et
al., 1991; Kim-Ha et al., 1991; Suter and Steward, 1991; Lantz
et al., 1992; Wang et al., 1994; Fig. 4A,B,D,E,I,J,M). Oocyte
accumulation of these RNAs is much less pronounced in
vasPH165 egg chambers in which Bic-D RNA localization is
essentially undetectable (Fig. 4C), and the concentration of orb
RNA in the oocyte is only slightly above the levels in the nurse
cells (Fig. 4F). In vasPH165 egg chambers, osk RNA is also not
observed to accumulate in the oocyte in the germarium or first
vitellarial stages of development. Rather, osk RNA tends to
concentrate in a somewhat diffuse manner in the center of the
egg chamber (Fig. 4K,L). Finally, loss of vas function has the
least pronounced effect on the accumulation of nos RNA into
the oocyte, but even in this case oocyte localization is
incomplete and poorly maintained (Fig. 4N,O). 
Many oocyte-specific RNAs are still translated, and
accumulate in vas-null oocytes despite defects in
RNA localization
Despite the poor localization of orb RNA, ORB protein
accumulates efficiently in vasPH165 oocytes, although
somewhat later in oogenesis than in the wild-type (compare
Fig. 4H with Fig. 4G). NOS protein expression is also broadly
similar to wild-type in vasPH165 ovaries. The reduced number
of developing cysts in vasPH165 germaria complicates the
analysis, but the peak of NOS protein expression in 4- to 8-cell
cysts at the posterior of region 1 (Wang et al., 1994) remains
apparent in vasPH165 (Fig. 4P,Q). OSK protein is not detectably
translated in early oogenesis in wild-type nor in vasPH165 egg
chambers (Kim-Ha et al., 1995; Rongo et al., 1995; data not
shown).
In wild-type oocytes, BIC-D and EGALITARIAN (EGL)
proteins colocalize in the oocyte cytoplasm, in a posterior
crescent from stages 2-7 (Suter and Steward, 1991; Mach and
Lehmann, 1997; Fig. 5A,C,D). In vasPH165, BIC-D and EGL
are efficiently translated and are localized to the oocyte.
However, the two proteins are tightly concentrated in a focus
which, in higher magnification in both bright-field and
confocal microscopy, appears to be adjacent to the oocyte
nucleus (Fig. 5B,E, and data not shown).
vasPH165 egg chambers often degenerate, usually at
stage 6 but occasionally later
Most vasPH165 egg chambers develop into germline cysts
Fig. 4. Localization of various RNAs and
proteins in wild-type and vasPH165 ovaries.
Micrographs of wild-type ovaries are
arranged on the left of the vertical bar, and
micrographs of mutant ovaries are arranged
on the right. (A-C) In situ hybridizations
illustrating the distribution of Bic-D RNA in
(A,B) wild-type and (C) vasPH165/vasPH165
ovaries. Localized signal is virtually absent in
the vas mutant. (D-F) In situ hybridizations
illustrating the distribution of orb RNA in
(D,E) wild-type and (F) vasPH165/vasPH165
ovaries. Localized signal is much fainter in
the vas mutant. (G,H) Ovaries from (G) wild-
type and (H) vasPH165/vasPH165 females
stained with an antiserum recognizing ORB
protein. Despite the weak localization of orb
RNA to the oocyte in the vas mutant, ORB
protein is abundant and oocyte-specific from
about stage 5. In earlier stages of oogenesis,
ORB staining is much more diffuse in the vas
mutant than in the wild-type. (I-L) In situ
hybridizations illustrating the distribution of
osk RNA in (I,J) wild-type and (K,L)
vasPH165/vasPH165 ovaries. Accumulation of
osk RNA in the oocyte is greatly reduced in
the vas mutant, and diffuse signal is often
apparent in the center of egg chambers (K).
Weak localization to the oocyte is also
frequently observed (L). (M-O) In situ
hybridizations illustrating the distribution of
nos RNA in (M) wild-type and (N,O)
vasPH165/vasPH165 ovaries. The distribution of
nos RNA in vas mutant egg chambers is far
more diffuse than in the wild-type, but a
higher concentration of nos RNA in the
oocyte than in the nurse cells is usually
apparent. (P,Q) Ovaries from (P) wild-type and (Q) vasPH165/vasPH165 females stained with an antiserum recognizing NOS protein. The peak of
NOS expression in developing cysts at the posterior of germarium region 1 (Wang et al., 1994) is apparent in both the wild-type and mutant
ovaries (arrowheads). For each probe and antiserum presented, the control and vasPH165/vasPH165 stainings were processed in parallel, and color
reactions proceeded for identical lengths of time.
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containing 15 nurse cells and a posteriorly localized oocyte.
These appear normal until about stage 6, whereupon all the
nuclei undergo pycnosis and further development ceases (Fig.
6A). Approximately 70% of all vasPH165 egg chambers
examined terminate development in this manner. A minority
(approx. 20%) of vasPH165 oocytes continue developing beyond
stage 6; most of these are blocked at stage 9-10, after which
the oocyte often loses its integrity at the anterior end, and nurse
cell nuclei invade the region of the egg chamber normally
occupied only by the oocyte (Fig. 6B). Finally, we found that
a small number of oocytes produced by vasPH165 females
complete oogenesis, but that these frequently have duplicated
micropyles at both the anterior and posterior ends (Fig. 6C).
These eggs also often have dorsal appendage defects consistent
with ventralization of the chorion: of 73 eggs analyzed, 14
(19%) lacked dorsal appendages; 48 (66%) had a single fused
dorsal appendage; and only 11 (15%) had two dorsal
appendages.
vas activity is required for efficient accumulation of
GRK protein
The phenotypes of late-stage vasPH165 oocytes suggest that the
GRK signalling pathway (González-Reyes et al., 1995; Roth
et al., 1995) may be inactive in these ovaries, and led us to
investigate the expression and distribution of grk RNA and
protein in vasPH165. Unlike Bic-D, orb, osk and nos RNA,
localization of grk RNA to the oocyte remains highly efficient
in vasPH165 egg chambers (Fig. 7). However, while in wild-type
oocytes from about stage 2-3 the distribution of grk RNA forms
an obvious posterior crescent (Fig. 7A), grk RNA remains
tightly concentrated in an extremely small area in vasPH165
oocytes (Fig. 7B), similar to the BIC-D/EGL localization
pattern in these oocytes (Fig. 5). Later in oogenesis, grk RNA
becomes anteriorly localized in both wild-type and vasPH165
oocytes, although in the mutant its distribution may extend
further ventrally (Fig. 7C and D).
Despite the relatively normal accumulation of grk RNA in
vasPH165 oocytes, and unlike the other proteins discussed
above, the effects of a loss of vas activity are striking with
regard to GRK protein accumulation; essentially no localized
GRK is observed in vasPH165 oocytes (Fig. 7E and F).
Furthermore, as measured on western blots, the level of GRK
protein is greatly reduced in vasPH165 ovaries as compared with
wild-type (Fig. 7G). Upon overexposure of such western blots
a small amount of GRK can be detected in both grkHK36 and
vasPH165 extracts (Neuman-Silberberg and Schüpbach, 1996;
data not shown). As grk is required for specification of dorsal
and posterior follicle structures, the duplicated micropyles and
dorsal appendage defects found in vasPH165 eggs (and in eggs
produced by other vas alleles; Lehmann and Nüsslein-Volhard,
1991; Schüpbach and Wieschaus, 1991) are likely to be caused
by the reduced level of GRK in vas mutants. These results also
suggest that VAS may activate GRK translation in wild-type
oocytes.
We examined the organization of the microtubule
cytoskeleton in vasPH165 oocytes using a khc:lacZ reporter
gene construct (Clark et al., 1994). In the minority of vasPH165
egg chambers that develop normally through stage 10 and can
thus be assessed in this way, the distribution of KHC- b -gal in
oocytes is similar to that in the wild-type (Fig. 7H-M), with
the exception that the intensity of signal is much lower in
mutant egg chambers. The reduced signal may indicate that
only a subset of microtubules are correctly organized in
vasPH165 oocytes. An alternative explanation, that VAS may be
required for efficient translation of KHC- b -gal protein in
oocytes, is formally possible.
DISCUSSION
Partially redundant roles for VAS in early oogenesis
We have isolated a null allele of vas, vasPH165, and its analysis
reveals that VAS is involved in many stages of oogenesis,
including cystocyte differentiation, oocyte differentiation, and
specification of anterior-posterior polarity in the developing
cysts. However, the phenotype of vasPH165 is inconsistent with
a total failure of any of these processes, indicating that VAS
has a partially redundant role in bringing them about. Some
vas-null egg chambers, namely those with two oocytes or with
mislocalized oocytes (Fig. 3C,D) are similar to those produced
in spn-A, spn-B, spn-C, spn-D and homeless (spn-E) mutants
(González-Reyes and St Johnston, 1994; Gillespie and Berg,
1995; González-Reyes et al., 1997). Furthermore, the vas-null
oocyte nucleus appears to be very similar to those observed in
spn mutants (Fig. 3F, González-Reyes et al., 1997), and defects
in anterodorsal accumulation of grk mRNA in stage 9 have also
been reported for spn mutants (Gillespie and Berg, 1995;
González-Reyes et al., 1997). It is likely that vas and the spn
genes have overlapping functions in oocyte determination, and
it is noteworthy in this context that homeless, which, like vas,
is required in the germline, encodes a DE-H-box protein
somewhat related to VAS. A role for the spn gene products in
translational activation of grk has been suggested (González-
Reyes et al., 1997). Construction of multiple mutants with
vasPH165 and spn mutations will be important in understanding
the degree to which their functions overlap. 
vas and nos are both required for germline cyst
development
We have observed a decrease in the number of developing
germline cysts in vasPH165 ovaries, and a similar, but more
severe, phenotype occurs in ovaries from females null for nos
function (Fig. 2; Wang et al., 1994; Curtis et al., 1997).
Because of the similarities between this aspect of the vas and
nos mutant phenotypes, and because VAS has been implicated
in translational activation of nos in the pole plasm (Gavis et al.,
1996; Dahanukar and Wharton, 1996), it is tempting to
speculate that VAS and NOS function in the same pathway to
promote germline cyst development, and that VAS may
activate (but not be absolutely essential for) translation of NOS
in this stage of germline development as well. Our
immunostaining for NOS neither supports nor refutes this
possibility. While we see no obvious lack of NOS in vasPH165
germaria (Fig. 4Q), it is presently impossible to detect
differences in NOS levels in stem cells or cystoblasts, as even
in wild-type ovaries these cells are not detectably stained with
NOS antibody (Wang et al., 1994; Fig. 4Q). The higher level
of NOS in 4-8 cell cysts, which appears to be unaffected by
vasPH165, would not be responsible for cyst development, as it
occurs at a later developmental stage than that at which the
cysts are blocked in nosRC ovaries.
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The reduction in the number of developing germline cysts
we observe in vas and nos null mutants could result from a
failure of the pole cells to migrate to the gonad during
embryogenesis, a failure of the germ cells to regulate the cell
cycle or to respond to cell division signals, or from
inappropriate differentiation of stem cells into cystoblasts,
depleting the germarium of proliferative stem cells. Of these
three possibilities, we do not think the defect involves pole cell
migration, as we never observe completely agametic ovaries in
vas or nos mutants. Agametic ovaries are observed even in
cases where pole cell migration is incompletely blocked, such
as in the progeny of AS-Pgc females (Nakamura et al., 1996).
Direct assessment of the role of zygotic VAS in pole cell
migration is confounded by the fact that maternal VAS
perdures until embryonic stage 15-16, long after pole cell
migration is complete.
Different threshold levels of VAS are required for its
various activities
In wild-type flies, vas is abundantly expressed in the female
germline, and, while VAS is concentrated at the posterior pole
of the oocyte from stage 10 of oogenesis, easily detectable
levels of VAS are present uniformly throughout the early
embryo (Lasko and Ashburner, 1990). These uniform levels are
sufficient for ectopic posterior somatic structures to develop in
circumstances where OSK is present outside of the pole plasm,
for instance in females overexpressing osk or carrying the
P[oskBRE–] transgene (Smith et al., 1992; Kim-Ha et al.,
1995). For embryos produced by females carrying a Bic-D
dominant allele, ectopic posterior segments form dependent on
vas activity (Mohler and Wieschaus, 1986), but ectopic pole
cells do not form, suggesting that the threshold level of VAS
necessary for determination of the posterior soma is less than
that necessary to induce formation of pole cells (Wharton and
Struhl, 1989). A much lower threshold level of VAS is required
in early oogenesis than for either later function, since vasLYG2
homozygotes, which produce very low levels of unaltered VAS
(Fig. 1C), lay a far larger number of eggs than do vasPH165
homozygotes, and show defects in oogenesis at lower
penetrance and of less severity than for the null (S. S. and P.
L., unpublished observations). 
RNA localization is dispensable for localizing
proteins to the early oocyte
A comparison of the distribution of RNAs and proteins in vas-
null egg chambers suggests that localization of RNAs, such as
Bic-D and orb, is largely redundant for targeting their proteins
to the oocyte. Furthermore, as most vas-null egg chambers
proceed through development at least to stage 6, despite the
very weak localization of such RNAs, it can also be argued that
RNA localization is relatively unimportant for the functions of
these genes. Therefore translational control, or protein
targeting by means independent of RNA localization, must
have a critical role in establishing the correct distribution of
these molecules. This is perhaps similar to the interplay
between translational control and RNA localization apparent in
later oogenesis and in embryos; targeting of OSK and NOS to
the posterior pole is accomplished through a combination of
RNA localization and translational repression of the
unlocalized RNA (Kim-Ha et al. 1995; Markussen et al., 1995;
Rongo et al., 1995; Gavis et al., 1996; Smibert et al., 1996),
and, at least for nos, it has been argued that RNA localization
comes about as a consequence of translational regulation
(Dahanukar and Wharton, 1996).
Two separable stages of oocyte localization for grk
RNA and BIC-D/EGL?
In vasPH165 ovaries, grk RNA and the BIC-D/EGL complex
still localize efficiently to the oocyte, but these molecules are
concentrated in a tight focus rather than being distributed more
widely in the oocyte cytoplasm. This suggests that in wild-type
egg chambers, localization of these molecules may occur in
two steps: a vas-independent step, which concentrates them in
the oocyte, and a second step which distributes them to a
specific region within the oocyte, depending directly or
indirectly on vas activity. Alternatively, loss of vas function
results in the formation of a novel structure or structures in the
oocyte cytoplasm which trap grk RNA and the BIC-D/EGL
complex. The distribution of BIC-D and EGL is unaffected in
grkHK36 ovaries, indicating that the abnormal localization of
these two proteins in vasPH165 oocytes is not a consequence of
the failure to accumulate GRK in vasPH165 (data not shown).
We have found that vas-null mutations affect some of the same
processes as do Bic-D and egl mutations; namely, oocyte
determination (in rare 16-nurse-cell and two-oocyte egg
chambers) and establishment of dorsal-ventral polarity (Swan
and Suter, 1996; Mach and Lehmann, 1997; this paper). In this
context, it is possible that these vas phenotypes are a result of
the altered distribution of BIC-D/EGL we observed. The
altered distribution of grk RNA within the early oocyte is
similar to that observed in maelstrom (mael) mutants which
affect the organization of oocyte microtubules (Clegg et al.,
1997). However, unlike in vas-null egg chambers in which
many RNAs, such as osk, are poorly transported from the nurse
cells to the oocyte (Fig. 4), mael only affects RNA distribution
within the oocyte (Clegg et al., 1997). Furthermore, posterior
localization of KHC-b GAL in vas-null oocytes (Fig. 7)
suggests that the organization of the microtubule cytoskeleton
is at least partially maintained.
Is VAS a direct activator of GRK translation? 
In the yeast S. cerevisiae, a protein highly similar to VAS,
DED1p, has recently been implicated in translation initiation
(Chuang et al., 1997; de la Cruz et al., 1997). While the loss-
of-function experiments presented here cannot distinguish
whether VAS is required directly or indirectly for GRK
accumulation, a simple model which takes into account the
molecular nature of VAS and explains the reduction of GRK
protein expression in vas-null ovaries is that VAS interacts
directly with grk RNA and activates its translation. This is
consistent, as well, with the striking reduction we observed in
GRK accumulation in vas-null oocytes despite the high level
of grk RNA in these oocytes. Importantly, other RNAs, such
as Bic-D and orb, whose localization to the oocyte is more
severely perturbed in vas-null ovaries, are still translated at
levels comparable to wild-type in vas-null oocytes.
Nevertheless, demonstration of a direct effect of VAS on grk
translation must await more detailed experimentation.
Bacterially expressed VAS has been demonstrated to bind RNA
in vitro (Liang et al., 1994). However, no specificity for RNA
binding by VAS in vitro has thus far been demonstrated, though
grk was not among the RNAs tested in these in vitro binding
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experiments. There appears to be elaborate posttranscriptional
regulation of GRK in the developing oocyte, involving the
activities of numerous genes. In addition to vas, the genes
aubergine and encore have been implicated as essential for
efficient GRK accumulation (Wilson et al., 1996; Hawkins et
al., 1997). 
Reduction of GRK activity explains only a subset of
vas phenotypes
Duplication of anterior vitelline membrane structures occurs in
strong grk mutant alleles, and GRK signalling has been
implicated in the specification of posterior polar follicle cells
(González-Reyes et al., 1995; Roth et al., 1995). We
demonstrate in this paper that many of the oocytes that
complete oogenesis in a loss-of-function vas mutant have
duplicated micropyles and/or fused or reduced dorsal
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Fig. 5. (A,B) Ovaries from (A) wild-type and (B) vasPH165/vasPH165
females stained with a monoclonal antibody recognizing BIC-D
protein. In the vas mutant, BIC-D protein is localized in a tight focus
adjacent to the oocyte nucleus throughout previtellogenic stages of
oogenesis. (C-E) Ovaries from (C,D) wild-type and (E)
vasPH165/vasPH165 females stained with an antiserum recognizing
EGL protein. The distribution of EGL is identical to that of BIC-D in
both the wild-type and the vas mutant.
Fig. 6. Phenotypes of vas-null egg chambers affecting later stages of
oogenesis. (A) Confocal micrograph of a vasPH165/vasPH165 ovariole,
stained with the nuclear dye Oli-Green, showing pycnosis and
degeneration after stage 6. (B) Confocal micrograph of a
vasPH165/Df(2L)A267 egg chamber, stained with Oli-Green and Texas
Red-phalloidin, illustrating a nurse cell nucleus invading the anterior
of a stage-10 oocyte. (C) Nomarski optics image of a
vasPH165/Df(2L)A267 egg chamber with duplicated micropyles
(arrows). The phenotypes depicted in B and C are also observed in
vasPH165/vasPH165 ovaries, at a similar frequency to
vasPH165/Df(2L)A267. 
Fig. 7. (A-D) In situ hybridizations illustrating the distribution of grk
RNA in (A,C) wild-type and (B,D) vasPH165/vasPH165 ovaries. In the
vas mutant, grk RNA is localized in a tight focus within the oocyte
throughout pre-vitellogenic stages of oogenesis. This distribution
resolves into an anterior ring at stage 8, with a variably higher
concentration at the anterodorsal corner, but not so sharp an
asymmetry as is evident in the wild-type. (E-F) Ovaries from (E)
wild-type and (F) vasPH165/vasPH165 females stained with an
antiserum recognizing GRK protein (Neuman-Silberberg and
Schüpbach, 1996). Essentially no localized signal is observed in the
vas mutant. For both the in situ hybridization and antibody staining
reactions, the control and vasPH165/vasPH165 stainings were processed
in parallel, and color reactions proceeded for identical lengths of
time. (G) Western blot prepared from extracts of ovaries dissected
from OreR, wild-type; grk, grkHK36/grkHK36; vas, vasPH165/vasPH165
females, and probed with the antiserum directed against GRK (top
panel) or with an antiserum directed against eIF4A (Lavoie, 1995) as
a loading control (bottom panel). GRK protein level is greatly
reduced in the grkHK36 and vasPH165 extracts. (H-M) Distribution of
b -galactosidase activity in ovaries bearing the khc:lacZ transgene
(Clark et al., 1994). H-J) Stage-8, -9, and -10 egg chambers from
CyO/vasPH165; khc:lacZ individuals. (K-M) Stage-8, -9, and -10 egg
chambers from vasPH165/vasPH165; khc:lacZ individuals. The control
and vasPH165/vasPH165 stainings were processed in parallel for
identical lengths of time.
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appendages, and four other vas alleles (PW72, QS17, AQB3,
RG53) have previously been shown to produce eggs with fused
and reduced dorsal appendages when hemizygous over
Df(2L)osp29 (Schüpbach and Wieschaus, 1991). All of these
phenotypes resemble those observed in grk mutants, making it
likely that these aspects of the vas mutant phenotype are
brought about by a reduction of GRK activity, particularly
since we show that GRK accumulation is negligible in vas-null
oocytes. However, aspects of the vas-null phenotype which
manifest themselves earlier in oogenesis, such as the reduced
number of developing cysts, the defects in RNA localization to
the oocyte, and the aberrant localization of BIC-D and EGL
within the oocyte, are not found in grk mutant ovaries (Fig. 2;
S.S. and P.L., unpublished results). This suggests that VAS may
regulate the activity of numerous genes. Evidence similar to
that presented here implicates VAS in translational activation
of Short OSK in the pole plasm (Markussen et al., 1995).
Furthermore, it is possible that VAS regulates translation of
other, presently unknown, RNAs whose products are involved
in establishing cytoskeletal polarity in the early cyst and/or in
localizing RNAs to the oocyte. 
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